CAS 2190490-31-2
:Formule :C19H16ClFN4O3
InChI :InChI=1S/C19H16ClFN4O3/c1-28-16-8-14-11(7-15(16)25-17(26)4-5-18(25)27)19(23-9-22-14)24-10-2-3-13(21)12(20)6-10/h2-3,6-9,17,26H,4-5H2,1H3,(H,22,23,24)
Code InChI :YYROAISCXBYHNT-UHFFFAOYSA-N
SMILES :COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)N4C(CCC4=O)O
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produits trouvés.
1-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one (Dacomitinib Impurity)
CAS :1-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one (Dacomitinib Impurity)Formule :C19H16ClFN4O3Degré de pureté :98%Masse moléculaire :402.811-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one (Dacomitinib Impurity)
CAS :Formule :C19H16ClFN4O3Degré de pureté :98%Masse moléculaire :402.8067Dacomitinib impurity 3
CAS :Dacomitinib impurity 3 is a contaminant found in Dacomitinib.Formule :C19H16ClFN4O3Masse moléculaire :402.811-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one (Dacomitinib Impurity)
CAS :Degré de pureté :98%Masse moléculaire :402.81Des-(4-(1-piperidinyl)-2-Butenamide) Dacomitinib-5-hydroxypyrrolidin-2-one
CAS :Produit contrôléApplications Des-(4-(1-piperidinyl)-2-Butenamide) Dacomitinib-5-hydroxypyrrolidin-2-one is a derivative of Dacomitinib (D101575), which is an Erb-inhibitor, or an inhibitor of the members of the epidermal growth factor receptor family. Used as an ant-cancer agent due to observation of over-expressed epidermal growth factor receptor in nearly all cases of squamous cell carcinoma in the head and neck.
References Williams, J. et al.: PLoS., 9, e98557 (2014); Peters, S. et al.: Canc. Treatment Rev., 40, 917 (2014);Formule :C19H16ClFN4O3Couleur et forme :NeatMasse moléculaire :402.807
